SQZ Biotechnologies (SQZ) Competitors

$0.02 0.00 (0.00%)

As of 05/4/2026

SQZ vs. SGLY, CISS, USDP, YELL, and AIRTP

Should you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include Singularity Future Technology (SGLY), C3is (CISS), USD Partners (USDP), Yellow (YELL), and Air T (AIRTP). These companies are all part of the "transportation" industry.

How does SQZ Biotechnologies compare to Singularity Future Technology?

Singularity Future Technology (NASDAQ:SGLY) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

: Singularity Future Technology has higher earnings, but lower revenue than SQZ Biotechnologies. Singularity Future Technology is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Singularity Future Technology $1.81M 1.08 -$3.91M -$3.06 N/A
SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A
: Singularity Future Technology has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, SQZ Biotechnologies has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500.
: In the previous week, Singularity Future Technology's average media sentiment score of 0.00 equaled SQZ Biotechnologies'average media sentiment score.
Company Overall Sentiment
Singularity Future Technology Neutral
SQZ Biotechnologies Neutral
: 4.1% of Singularity Future Technology shares are held by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are held by institutional investors. 10.2% of Singularity Future Technology shares are held by company insiders. Comparatively, 16.0% of SQZ Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Singularity Future Technology
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
SQZ Biotechnologies
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: SQZ Biotechnologies has a net margin of -369.96% compared to Singularity Future Technology's net margin of -987.08%. Singularity Future Technology's return on equity of -56.78% beat SQZ Biotechnologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Singularity Future Technology -987.08% -56.78% -20.64%
SQZ Biotechnologies -369.96% -119.83% -59.90%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Singularity Future Technology	$1.81M	1.08	-$3.91M	-$3.06	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

Company	Overall Sentiment
Singularity Future Technology	Neutral
SQZ Biotechnologies	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Singularity Future Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Singularity Future Technology	-987.08%	-56.78%	-20.64%
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

Summary

SQZ Biotechnologies beats Singularity Future Technology on 7 of the 12 factors compared between the two stocks.

How does SQZ Biotechnologies compare to C3is?

SQZ Biotechnologies (NYSE:SQZ) and C3is (NASDAQ:CISS) are both small-cap transportation companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

: 38.5% of SQZ Biotechnologies shares are owned by institutional investors. Comparatively, 10.5% of C3is shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: In the previous week, C3is had 1 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 1 mentions for C3is and 0 mentions for SQZ Biotechnologies. SQZ Biotechnologies' average media sentiment score of 0.00 equaled C3is'average media sentiment score.
Company Overall Sentiment
SQZ Biotechnologies Neutral
C3is Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SQZ Biotechnologies
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
C3is
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: SQZ Biotechnologies has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500. Comparatively, C3is has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500.
: C3is has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than C3is, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A
C3is $34.76M 0.01 $10.47M -$1.13 thousand N/A
: C3is has a net margin of 30.13% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 2.38% beat SQZ Biotechnologies' return on equity.
Company Net Margins Return on Equity Return on Assets
SQZ Biotechnologies -369.96% -119.83% -59.90%
C3is 30.13% 2.38% 2.04%

Company	Overall Sentiment
SQZ Biotechnologies	Neutral
C3is	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
C3is	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A
C3is	$34.76M	0.01	$10.47M	-$1.13 thousand	N/A

Company	Net Margins	Return on Equity	Return on Assets
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%
C3is	30.13%	2.38%	2.04%

Summary

C3is beats SQZ Biotechnologies on 8 of the 13 factors compared between the two stocks.

How does SQZ Biotechnologies compare to USD Partners?

USD Partners (NYSE:USDP) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

: 0.1% of USD Partners shares are owned by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are owned by institutional investors. 2.6% of USD Partners shares are owned by company insiders. Comparatively, 16.0% of SQZ Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: In the previous week, USD Partners' average media sentiment score of 0.00 equaled SQZ Biotechnologies'average media sentiment score.
Company Overall Sentiment
USD Partners Neutral
SQZ Biotechnologies Neutral
: USD Partners has a beta of -0.17, indicating that its share price is 117% less volatile than the S&P 500. Comparatively, SQZ Biotechnologies has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500.
: USD Partners has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than USD Partners, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
USD Partners $72.32M 0.00 $17.77M -$1.06 N/A
SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A
: USD Partners has a net margin of -94.39% compared to SQZ Biotechnologies' net margin of -369.96%. USD Partners' return on equity of 0.00% beat SQZ Biotechnologies' return on equity.
Company Net Margins Return on Equity Return on Assets
USD Partners -94.39% N/A -28.33%
SQZ Biotechnologies -369.96% -119.83% -59.90%

Company	Overall Sentiment
USD Partners	Neutral
SQZ Biotechnologies	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USD Partners	$72.32M	0.00	$17.77M	-$1.06	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

Company	Net Margins	Return on Equity	Return on Assets
USD Partners	-94.39%	N/A	-28.33%
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

Summary

USD Partners beats SQZ Biotechnologies on 7 of the 11 factors compared between the two stocks.

How does SQZ Biotechnologies compare to Yellow?

Yellow (NASDAQ:YELL) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

: 35.7% of Yellow shares are owned by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are owned by institutional investors. 4.2% of Yellow shares are owned by company insiders. Comparatively, 16.0% of SQZ Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: In the previous week, SQZ Biotechnologies' average media sentiment score of 0.00 beat Yellow's score of -0.59 indicating that SQZ Biotechnologies is being referred to more favorably in the news media.
Company Overall Sentiment
Yellow Negative
SQZ Biotechnologies Neutral
: Yellow has a beta of 2.79, indicating that its share price is 179% more volatile than the S&P 500. Comparatively, SQZ Biotechnologies has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500.
: Yellow has a net margin of -1.65% compared to SQZ Biotechnologies' net margin of -369.96%. Yellow's return on equity of -6.10% beat SQZ Biotechnologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Yellow -1.65% -6.10% -3.54%
SQZ Biotechnologies -369.96% -119.83% -59.90%
: Yellow has higher revenue and earnings than SQZ Biotechnologies. Yellow is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Yellow $4.85B 0.00 $21.80M -$1.55 N/A
SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A

Company	Overall Sentiment
Yellow	Negative
SQZ Biotechnologies	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Yellow	-1.65%	-6.10%	-3.54%
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Yellow	$4.85B	0.00	$21.80M	-$1.55	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

Summary

Yellow beats SQZ Biotechnologies on 7 of the 12 factors compared between the two stocks.

How does SQZ Biotechnologies compare to Air T?

Air T (NASDAQ:AIRTP) and SQZ Biotechnologies (NYSE:SQZ) are both transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

: Air T has a net margin of 0.00% compared to SQZ Biotechnologies' net margin of -369.96%. Air T's return on equity of 0.00% beat SQZ Biotechnologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Air T N/A N/A N/A
SQZ Biotechnologies -369.96% -119.83% -59.90%
: 38.5% of SQZ Biotechnologies shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Air T has higher revenue and earnings than SQZ Biotechnologies.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Air T $272.47M N/A N/A N/A N/A
SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A
: In the previous week, Air T had 1 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 1 mentions for Air T and 0 mentions for SQZ Biotechnologies. Air T's average media sentiment score of 0.00 equaled SQZ Biotechnologies'average media sentiment score.
Company Overall Sentiment
Air T Neutral
SQZ Biotechnologies Neutral

Company	Net Margins	Return on Equity	Return on Assets
Air T	N/A	N/A	N/A
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Air T	$272.47M	N/A	N/A	N/A	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

Company	Overall Sentiment
Air T	Neutral
SQZ Biotechnologies	Neutral

Summary

Air T beats SQZ Biotechnologies on 5 of the 7 factors compared between the two stocks.

Get SQZ Biotechnologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SQZ vs. The Competition

Export

Metric	SQZ Biotechnologies	Biological Products Industry	Medical Sector	NYSE Exchange
Market Cap	$708K	$328.15M	$6.25B	$22.95B
Dividend Yield	N/A	N/A	2.73%	4.03%
P/E Ratio	-0.01	N/A	29.04	28.58
Price / Sales	0.04	189.48	476.61	23.58
Price / Cash	N/A	22.44	27.62	19.03
Price / Book	0.01	4.73	9.67	4.68
Net Income	-$79.46M	-$132.96M	$3.55B	$1.07B
7 Day Performance	N/A	6.97%	1.70%	0.89%
1 Month Performance	N/A	4.03%	5.62%	6.56%
1 Year Performance	N/A	37.44%	34.42%	31.66%

SQZ Biotechnologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SQZ SQZ Biotechnologies	N/A	$0.02 flat	N/A	N/A	$708K	$18.16M	N/A	1,620
SGLY Singularity Future Technology	0.4141 of 5 stars	$0.46 -4.6%	N/A	N/A	$1.92M	$1.81M	N/A	40	Gap Down
CISS C3is	0.3991 of 5 stars	$3.30 -8.1%	N/A	N/A	$482K	$34.76M	N/A	N/A	Analyst Upgrade Gap Down
USDP USD Partners	N/A	$0.00 flat	N/A	N/A	$68K	$72.32M	N/A	90
YELL Yellow	N/A	$0.00 -99.7%	N/A	N/A	$21K	$4.85B	N/A	30,000	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SQZ) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SQZ Biotechnologies (SQZ) Competitors

SQZ vs. SGLY, CISS, USDP, YELL, and AIRTP

How does SQZ Biotechnologies compare to Singularity Future Technology?

Summary

How does SQZ Biotechnologies compare to C3is?

Summary

How does SQZ Biotechnologies compare to USD Partners?

Summary

How does SQZ Biotechnologies compare to Yellow?

Summary

How does SQZ Biotechnologies compare to Air T?

Summary

Media Sentiment Over Time

SQZ vs. The Competition

SQZ Biotechnologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SQZ Biotechnologies (SQZ) Competitors

SQZ vs. SGLY, CISS, USDP, YELL, and AIRTP

How does SQZ Biotechnologies compare to Singularity Future Technology?

Summary

How does SQZ Biotechnologies compare to C3is?

Summary

How does SQZ Biotechnologies compare to USD Partners?

Summary

How does SQZ Biotechnologies compare to Yellow?

Summary

How does SQZ Biotechnologies compare to Air T?

Summary

Media Sentiment Over Time

SQZ vs. The Competition

SQZ Biotechnologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools